Krempa David — SEC Form 4 filings
SEC reporting owner CIK 1968254. 11 Form 4 filings on record with FilingPulse; latest filed 2026-08-24.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-15 to 2026-08-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 3 filings — 159,000 shares, $5,360,991 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
- Largest priced transaction: sale of 25,000 shares @ $65.07 ($1,626,750) in Eton Pharmaceuticals, Inc., filed 2026-08-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Eton Pharmaceuticals, Inc. (ETON) | Chief Business Officer | 11 | — | 9 legs · 159,000 sh · $5,360,991 | 25 |
Form 4 filings — Krempa David
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-24 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise (M): 25,000 @ $7.31 · Sale (S): 25,000 @ $65.07 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 128,985 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise (M): 10,000 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2026-05-27 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Option exercise (M): 30,591 @ $3.58 · Sale (S): 32,963 @ $33.22 · Sale (S): 9,315 @ $33.88 · Sale (S): 519 @ $35 · Option exercise (M): 25,000 @ $1.38 · Option exercise (M): 12,524 @ $1.37 · +9 more | EDGAR |
| 2026-01-14 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Tax withholding (F): 1,942 @ $15.62 · Grant/award (A): 40,655 (derivative) @ $0 · Grant/award (A): 25,856 (derivative) @ $0 | EDGAR |
| 2025-12-12 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Tax withholding (F): 6,264 @ $17 · Grant/award (A): 5,300 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Sale (S): 16,977 @ $14.92 · Sale (S): 6,800 @ $14.77 · Sale (S): 10,223 @ $14.73 | EDGAR |
| 2025-01-06 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 38,621 (derivative) @ $0 · Grant/award (A): 25,876 (derivative) @ $0 | EDGAR |
| 2024-10-04 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 42,088 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | Eton Pharmaceuticals, Inc. (ETON) | Grant/award (A): 144,677 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1968254 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →